HER3 is a determinant for poor prognosis in melanoma

Reschke, M.; Mihic-Probst, D.; van der Horst, E. H.; Knyazev, P.; Wild, P. J.; Hutterer, M.; Meyer, S.; Dummer, R.; Moch, H.; Ullrich, A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

HER3 is a determinant for poor prognosis in melanoma

MPS-Authors

/persons/resource/persons78562

Reschke, M.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78233

Knyazev, P.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78812

Ullrich, A.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Reschke, M., Mihic-Probst, D., van der Horst, E. H., Knyazev, P., Wild, P. J., Hutterer, M., et al. (2008). HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research, 14(16), 5188-5197.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-5C20-F

Abstract

There is no abstract available